Abstract P4-21-24: Development of mathematical prediction models to identify disease-free survival events for HER2-positive primary breast cancer patients treated by neoadjuvant chemotherapy and trastuzumab
In this study we looked at the prognostic and predictive effect of B-cells in the immune infiltrate of 178 IBC and 247 nIBC patients.MethodsTIL scoring was done on standard H77/4_Supplement/P4-21-24/table1T1Category 1 (
Source: Cancer Research - Category: Cancer & Oncology Authors: M Takada, M Sugimoto, N Masuda, H Iwata, K Kuroi, H Yamashiro, S Ohno, H Ishiguro, T Inamoto, M Toi Tags: Poster Session Abstracts Source Type: research
More News: Breast Cancer | Cancer | Cancer & Oncology | Chemotherapy | Genetics | HER2 | Herceptin | Inflammatory Breast Cancer | Neoadjuvant Chemotherapy Therapy | Neoadjuvant Therapy | Study